Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/1998
08/20/1998WO1998018931A3 Streptococcus pneumoniae polynucleotides and sequences
08/20/1998WO1998017689A3 Il-12 gene expression and delivery systems and uses
08/20/1998WO1998017284A3 Inhibition of cap-independent protein synthesis and hiv-tar translation by heparin or heparin mimetics, and methods for gene therapy
08/20/1998WO1998014596A3 Disease associated protein tyrosine phosphatases
08/20/1998CA2282683A1 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
08/20/1998CA2281086A1 Oligomers which inhibit expression of collagen genes
08/20/1998CA2281000A1 Diagnosis and treatment of glaucoma
08/20/1998CA2280968A1 Secreted proteins and polynucleotides encoding them
08/20/1998CA2280839A1 Polynucleotide vaccine formulations
08/20/1998CA2280722A1 Compositions for the inhibition of bone resorption
08/20/1998CA2280700A1 Expression of active human factor ix in mammary tissue of transgenic animals
08/20/1998CA2243984A1 Neural cell adhesion molecule splicing variants
08/19/1998EP0859058A2 Nucleic acid construct for expression of protease activatable substances
08/19/1998EP0859055A1 Cloning of a novel g-protein coupled 7tm receptor
08/19/1998EP0859053A1 Novel G-protein coupled receptor (HTADX50)
08/19/1998EP0859052A1 Cloning of human GPR14 receptor
08/19/1998EP0859008A2 Nucleic acid construct for the cell cycle regulated expression of structural genes
08/19/1998EP0858506A2 Genetic induction of receptors for targeted radiotherapy
08/19/1998EP0858503A1 METHODS FOR USE OF Mpl LIGANDS WITH PRIMITIVE HUMAN STEM CELLS
08/19/1998EP0858467A1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof
08/19/1998EP0858466A1 Use of protein gax for treating cancer
08/19/1998EP0858465A2 Anti-tumoral protein
08/19/1998EP0858346A1 Expression of cyclin g1 in tumors
08/19/1998EP0733057A4 Origin of replication complex genes, proteins and methods
08/19/1998EP0695170A4 Long-acting treatment by slow-release delivery of antisense oligodeoxyribonucleotides from biodegradable microparticles
08/19/1998CN1190991A Human chemokine beta-11 and human chemokine alpha-1
08/19/1998CN1190894A Method for identifying or isolating a molecule and molecules indentified thereby
08/19/1998CA2223020A1 Human protein kinase hoacf72
08/18/1998US5795963 Amyloid precursor protein in alzheimer's disease
08/18/1998US5795872 DNA construct for immunization
08/18/1998US5795870 Steroid ring with amine group side chains
08/18/1998US5795866 ETS1 gene: a human tumor suppressor gene
08/18/1998US5795790 Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs
08/18/1998US5795778 Using enzymatic rna compound
08/18/1998US5795768 Genetic engineering
08/18/1998US5795758 DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae
08/18/1998US5795757 DNA encoding threonyl tRNA synthetase from staphylococcus aureus
08/18/1998US5795735 Isolated polynucleotides encoding PKA-binding proteins and methods of producing the proteins recombinantly
08/18/1998US5795587 Stable lipid-comprising drug delivery complexes and methods for their production
08/18/1998CA2224123A1 Nucleic acid construct for the cell cycle regulated expression of structural genes
08/13/1998WO1998035048A2 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
08/13/1998WO1998035043A1 Human sdf-5 protein and compositions
08/13/1998WO1998035040A2 A single gene encoding aortic-specific and striated-specific muscle cell isoforms and uses thereof
08/13/1998WO1998035039A1 Dendritic cell-derived growth factor
08/13/1998WO1998035036A1 Heregulin variants
08/13/1998WO1998035031A1 Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen
08/13/1998WO1998035028A2 An oncolytic/immunogenic complementary-adenoviral vector system
08/13/1998WO1998035024A1 New spumavirus isolated from humans
08/13/1998WO1998035020A2 Methods for modulating hematopoiesis and vascular growth
08/13/1998WO1998034952A2 Il-2 gene expression and delivery systems and uses
08/13/1998WO1998034910A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
08/13/1998WO1998034667A1 Gene therapeutic treatment of blood vessel associated disorders
08/13/1998WO1998034648A1 Formulation of stabilised cationic transfection agent(s)/nucleic acid particles
08/13/1998WO1998034640A2 Synthetic hiv gag genes
08/13/1998WO1998034639A1 Immunization against endogenous molecules
08/13/1998WO1998034637A1 Use of a polypeptide for obtaining a composition for detecting, preventing or treating a degenerative and/or autoimmune disease
08/13/1998WO1998034635A1 Methods and compositions for the inhibition of interleukin-12 production
08/13/1998WO1998030709A3 Non-immunogenic prodrugs and selectable markers for use in gene therapy
08/13/1998WO1998030693A3 Tumor necrosis factor receptor 5
08/13/1998WO1998024888A3 Polypeptides encoded by a human lipase-like gene, compositions and methods
08/13/1998WO1998022501A3 Secreted proteins and polynucleotides encoding them
08/13/1998WO1998011206A3 THERAPY FOR α-GALACTOSIDASE A DEFICIENCY
08/13/1998CA2280287A1 Dendritic cell-derived growth factor
08/13/1998CA2280275A1 New spumavirus isolated from humans
08/13/1998CA2280237A1 An oncolytic/immunogenic complementary-adenoviral vector system
08/13/1998CA2280195A1 Synthetic hiv gag genes
08/13/1998CA2280190A1 Il-2 gene expression and delivery systems and uses
08/13/1998CA2280051A1 Prostate specific regulatory nucleic acid sequences and transgenic non-human animals expressing prostate specific antigen
08/13/1998CA2279826A1 Immunization against endogenous molecules
08/13/1998CA2279575A1 Human sdf-5 protein and compositions
08/13/1998CA2278665A1 Formulation of stabilised cationic transfection agent(s)/nucleic acid particles
08/13/1998CA2278342A1 A single gene encoding aortic-specific and striated-specific muscle cell isoforms and uses thereof
08/13/1998CA2251999A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
08/12/1998EP0857787A2 Histidine kinase from Staphylococcus aureaus
08/12/1998EP0857786A1 RNA dependent amidotransferase B from Staphylococcus Aureus
08/12/1998EP0857785A1 RNA dependent amidotransferase C from Staphylococcus Aureus
08/12/1998EP0857783A2 Gene encoding sulfotransferase
08/12/1998EP0857782A2 Novel mammalian DD-1 gene
08/12/1998EP0857781A2 Human endoglingene promoter and use thereof
08/12/1998EP0857214A1 Novel saliva binding protein
08/12/1998EP0857213A1 Novel adherence factors of non pathogenic microorganisms and applications thereof for screening miroorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
08/12/1998EP0857212A2 Methods and compositions comprising glut-2 and glut-2 chimeras
08/12/1998EP0857210A1 Therapeutic antiangiogenic compositions and methods
08/12/1998EP0857209A1 Fibroblast growth factor 13
08/12/1998EP0857208A2 Chimaeric oligonucleotides and uses thereof in the identification of antisense binding sites
08/12/1998EP0804452A4 Recombinant c140 receptor and its agonists and antagonists
08/12/1998EP0701450B1 Recombinant viruses and their use in gene therapy
08/12/1998CN1190435A Method for large scale plasmid purification
08/12/1998CN1190402A Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
08/12/1998CA2223029A1 Canine parvovirus dna vaccines
08/11/1998US5792900 Genetic engineered neuron protein for treating nervous system disorder
08/11/1998US5792847 2' Modified Oligonucleotides
08/11/1998US5792845 Nucleotides encoding angiostatin protein and method of use
08/11/1998US5792751 Tranformation of cells associated with fluid spaces
08/11/1998US5792656 Methods of preparing genetically engineered cells that produce insulin in response to glucose
08/11/1998US5792651 Enhancement of the transfection efficiency of nucleic acids by using isopropanol in aqueous solutions
08/11/1998US5792648 Isolated, purified polynucleotide sequence encoding polypeptide having specified amino acid sequence
08/11/1998US5792639 Paraoxonase polypeptides and use therefor
08/11/1998US5792615 Synthetic oligomers having chirally pure phoshonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages
08/11/1998US5792462 Alphavirus RNA replicon systems
1 ... 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 ... 870